When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 11 Oct 2025
Last updated: 22 Aug 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • fatigue
  • oedema
  • nausea with/without vomiting
  • pruritus
  • skin and nail changes
  • restless legs
  • anorexia
  • infection-related glomerular disease

Other diagnostic factors

  • arthralgia
  • enlarged prostate gland
  • foamy-appearing urine
  • cola- or tea-coloured urine
  • rashes
  • dyspnoea
  • orthopnoea
  • seizures
  • retinopathy

Risk factors

  • diabetes mellitus
  • hypertension
  • age >50 years
  • childhood kidney disease
  • smoking
  • obesity
  • non-Hispanic black ethnicity
  • family history of CKD
  • autoimmune disorders
  • male sex
  • long-term use of non-steroidal anti-inflammatory drugs (NSAIDs)
  • high uric acid levels

Diagnostic investigations

1st investigations to order

  • renal chemistry
  • estimation of GFR using serum creatinine
  • estimation of GFR using cystatin C with or without serum creatinine
  • urinalysis
  • urinary albumin
  • renal ultrasound

Investigations to consider

  • kidney biopsy
  • plain abdominal radiograph
  • diabetes screen
  • mineral bone disorder assessment
  • anaemia assessment

Treatment algorithm

Contributors

Authors

Manisha Singh, MD
Manisha Singh

Associate Professor

Division of Nephrology

Department of Internal Medicine

Director Home Dialysis Program

Co-Director M2 Renal Module

University of Arkansas for Medical Sciences

Little Rock

AR

Disclosures

MS is an author of a reference cited in this topic.

Michelle W. Krause, MD, MPH
Michelle W. Krause

Professor of Medicine

Director, Integrated Medicine Service Line

Vice-Chair for Clinical Operations, Quality, and Efficiency

Department of Internal Medicine

University of Arkansas for Medical Sciences

Central Arkansas Veterans Healthcare System

Little Rock

AR

Disclosures

MWK declares that she has no competing interests.

Acknowledgements

Dr Manisha Singh and Dr Michelle Krause would like to gratefully acknowledge Professor Sudhir V. Shah, a previous contributor to this topic.

Disclosures

SVS declares that he has no competing interests.

Peer reviewers

Robert Toto, MD

Professor

Internal Medicine - Nephrology

Southwestern Medical School

The University of Texas Southwestern Medical Center at Dallas

Dallas

TX

Disclosures

RT declares that he has no competing interests.

Guy H. Neild, MD, FRCP, FRCPath

Professor of Nephrology

UCL Division of Medicine

University College London

London

UK

Disclosures

GHN declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024 Apr;105(4s):S117-314.Full text  Abstract

National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management. Nov 2021 [internet publication].Full text

Wong-You-Cheong JJ, Nikolaidis P, Katri G, et al; Expert Panel on Urologic Imaging. ACR appropriateness criteria® renal failure. J Am Coll Radiol. 2021 May;18(5s):S174-88.Full text  Abstract

Kalantar-Zadeh K, Jafar TH, Nitsch D, et al. Chronic kidney disease. Lancet. 2021 Aug 28;398(10302):786-802. Abstract

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017 Jul;7(1):1-59.Full text

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer